AU2002337803A1 - Sustained release pharmaceutical compositions - Google Patents
Sustained release pharmaceutical compositionsInfo
- Publication number
- AU2002337803A1 AU2002337803A1 AU2002337803A AU2002337803A AU2002337803A1 AU 2002337803 A1 AU2002337803 A1 AU 2002337803A1 AU 2002337803 A AU2002337803 A AU 2002337803A AU 2002337803 A AU2002337803 A AU 2002337803A AU 2002337803 A1 AU2002337803 A1 AU 2002337803A1
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical compositions
- sustained release
- release pharmaceutical
- sustained
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32740801P | 2001-10-03 | 2001-10-03 | |
US60/327,408 | 2001-10-03 | ||
PCT/US2002/031422 WO2003028653A2 (en) | 2001-10-03 | 2002-10-03 | Sustained release pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002337803A1 true AU2002337803A1 (en) | 2003-04-14 |
Family
ID=23276439
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002337803A Abandoned AU2002337803A1 (en) | 2001-10-03 | 2002-10-03 | Sustained release pharmaceutical compositions |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002337803A1 (en) |
WO (1) | WO2003028653A2 (en) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2500015A1 (en) | 2006-12-05 | 2012-09-19 | Landec Corporation | Delivery of drugs |
US20110218123A1 (en) | 2008-09-19 | 2011-09-08 | President And Fellows Of Harvard College | Creation of libraries of droplets and related species |
US8682440B2 (en) | 2009-08-03 | 2014-03-25 | Incube Labs, Llc | Swallowable capsule and method for stimulating incretin production within the intestinal tract |
US8721620B2 (en) | 2009-12-24 | 2014-05-13 | Rani Therapeutics, Llc | Swallowable drug delivery device and methods of drug delivery |
US9402806B2 (en) | 2010-12-23 | 2016-08-02 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US10639272B2 (en) | 2010-12-23 | 2020-05-05 | Rani Therapeutics, Llc | Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device |
US8734429B2 (en) | 2010-12-23 | 2014-05-27 | Rani Therapeutics, Llc | Device, system and methods for the oral delivery of therapeutic compounds |
US8846040B2 (en) | 2010-12-23 | 2014-09-30 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising etanercept for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US8969293B2 (en) | 2010-12-23 | 2015-03-03 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US8809269B2 (en) | 2010-12-23 | 2014-08-19 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US8764733B2 (en) | 2010-12-23 | 2014-07-01 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US8809271B2 (en) | 2010-12-23 | 2014-08-19 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising liraglutide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US9284367B2 (en) | 2010-12-23 | 2016-03-15 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US9415004B2 (en) | 2010-12-23 | 2016-08-16 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US9629799B2 (en) | 2010-12-23 | 2017-04-25 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US9149617B2 (en) | 2010-12-23 | 2015-10-06 | Rani Therapeutics, Llc | Device, system and methods for the oral delivery of therapeutic compounds |
US9283179B2 (en) | 2010-12-23 | 2016-03-15 | Rani Therapeutics, Llc | GnRH preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US9402807B2 (en) | 2010-12-23 | 2016-08-02 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US8980822B2 (en) | 2010-12-23 | 2015-03-17 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising pramlintide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US9259386B2 (en) | 2010-12-23 | 2016-02-16 | Rani Therapeutics, Llc | Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US9861683B2 (en) | 2010-12-23 | 2018-01-09 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US20160279068A1 (en) | 2013-11-08 | 2016-09-29 | President And Fellows Of Harvard College | Microparticles, methods for their preparation and use |
CN104434854B (en) * | 2014-12-10 | 2017-03-29 | 哈药集团技术中心 | A kind of minodronic acid tablet recipe and its preparation technology |
CN104398485B (en) * | 2014-12-10 | 2017-05-10 | 哈药集团技术中心 | Olmesartan medoxomil tablet and preparation method thereof |
CN104434855B (en) * | 2014-12-10 | 2017-02-01 | 哈药集团技术中心 | Memantine hydrochloride tablet and preparation method thereof |
CN108289797B (en) | 2015-10-13 | 2022-01-28 | 哈佛学院院长及董事 | Systems and methods for making and using gel microspheres |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4568559A (en) * | 1984-02-06 | 1986-02-04 | Biotek, Inc. | Composite core coated microparticles and process of preparing same |
US5874063A (en) * | 1991-04-11 | 1999-02-23 | Astra Aktiebolag | Pharmaceutical formulation |
CA2156408C (en) * | 1993-03-17 | 2005-02-15 | Daniel C. Duan | Aerosol formulation containing a polyester dispersing aid |
US6136294C1 (en) * | 1998-09-22 | 2002-09-24 | Aeropharm Technology Inc | Amino acid stabilized medical aerosol formulation |
-
2002
- 2002-10-03 AU AU2002337803A patent/AU2002337803A1/en not_active Abandoned
- 2002-10-03 WO PCT/US2002/031422 patent/WO2003028653A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003028653A3 (en) | 2004-03-11 |
WO2003028653A2 (en) | 2003-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002258563A1 (en) | Pharmaceutical formulations for sustained release | |
AU2002337803A1 (en) | Sustained release pharmaceutical compositions | |
AU781269C (en) | Pharmaceutical compositions | |
AU2002313236A1 (en) | Medicinal compositions | |
AU2001250420A1 (en) | Pharmaceutical compositions | |
AU2001274307A1 (en) | Pharmaceutical compositions | |
AUPR602501A0 (en) | Sustained release pharmaceutical composition | |
GB0111597D0 (en) | Pharmaceutical compositions | |
AU2002302147A1 (en) | Pharmaceutical composition | |
AU2003260803A1 (en) | Sustained release pharmaceutical composition | |
AU2001264264A1 (en) | Sustained release compositions | |
AU2002258221A1 (en) | Medicinal composition | |
AU2001248772A1 (en) | Sustained release drug compositions | |
AU2001273919A1 (en) | Pharmaceutical compositions | |
GB0104752D0 (en) | Pharmaceutical compositions | |
AU2003216503A1 (en) | Stable pharmaceutical compositions | |
AU2002354460A1 (en) | Medicinal composition | |
GB2382302B (en) | Pharmaceutical compositions | |
AUPR529701A0 (en) | Pharmaceutical composition | |
AU2002346223A1 (en) | Medicinal compositions | |
AU2001285737A1 (en) | Pharmaceutical compositions | |
AU2002326822A1 (en) | Pro-micelle pharmaceutical compositions | |
AU2002100921A4 (en) | Pharmaceutical composition | |
AUPS008402A0 (en) | Sustained release pharmaceutical composition | |
GB0126732D0 (en) | Pharmaceutical compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |